Xiong Cai
Hunan International Economics University(CN)Union Hospital(CN)Institute of International Education(US)Hunan University of Traditional Chinese Medicine(CN)First Affiliated Hospital of Hunan University of Traditional Chinese Medicine(CN)Huazhong University of Science and Technology(CN)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Pharmacological Effects of Natural Compounds, Phytochemistry and Biological Activities
Most-Cited Works
- → Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer(2010)261 cited
- → Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling(2012)239 cited
- → CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity(2010)212 cited
- → Sinomenine Versus NSAIDs for the Treatment of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis(2008)163 cited
- → CUDC-305, a Novel Synthetic HSP90 Inhibitor with Unique Pharmacologic Properties for Cancer Therapy(2009)111 cited
- → Sinomenine ameliorates arthritis via MMPs, TIMPs, and cytokines in rats